content

Sartorius, RoosterBio Partner to Advance the Manufacture of Exosomes

Sartorius has extended a strategic collaboration agreement with RoosterBio Inc. to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. The...

GHO Capital and The Vistria Group Complete Acquisition of Leading CDMO Alcami Corporation

Global Healthcare Opportunities, or GHO Capital Partners LLP ("GHO"), and The Vistria Group today announced that they have completed the acquisition of Alcami Corporation...

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality Biologics, a clinical-stage biotech company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers and autoimmune diseases, announced a...

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

WuXi Biologics , a leading global Contract Research, Development, and Manufacturing Organization announced a license agreement with GSK plc under which GSK will have...

Agilent Technologies Inc. Acquires Avida Biomed

Agilent Technologies Inc. has acquired Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing...

Moderna to Acquire OriCiro Genomics for $85M

Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010...

Capsida Biotherapeutics, Prevail Therapeutics Enter Strategic R&D Alliance

Capsida Biotherapeutics Inc. has entered a multi-year strategic collaboration with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Co., to develop genetic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read